INTERWEST VENTURE MANAGEMENT CO - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 26 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
INTERWEST VENTURE MANAGEMENT CO ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$7,383,000
+50.8%
388,7660.0%0.92%
-34.7%
Q3 2020$4,895,000
+4.1%
388,7660.0%1.41%
-63.8%
Q2 2020$4,704,000
+58.2%
388,7660.0%3.90%
+24.2%
Q1 2020$2,974,000
-57.0%
388,7660.0%3.14%
+5.3%
Q4 2019$6,924,000
+53.5%
388,7660.0%2.98%
+72.4%
Q3 2019$4,510,000
-47.6%
388,7660.0%1.73%
-37.8%
Q2 2019$8,611,000
-22.6%
388,7660.0%2.78%
-72.8%
Q1 2019$11,126,000
+44.9%
388,7660.0%10.22%
-5.2%
Q4 2018$7,678,000
-10.7%
388,7660.0%10.78%
+156.8%
Q3 2018$8,596,000
+220.9%
388,766
+17.8%
4.20%
+270.8%
Q2 2018$2,679,000
-14.4%
329,9420.0%1.13%
-14.1%
Q1 2018$3,128,000
-2.8%
329,9420.0%1.32%
+19.8%
Q4 2017$3,217,000
+44.8%
329,9420.0%1.10%
+90.3%
Q3 2017$2,221,000
-8.5%
329,9420.0%0.58%
+0.5%
Q2 2017$2,428,000
-5.8%
329,9420.0%0.58%
+4.9%
Q1 2017$2,577,000
+10.5%
329,9420.0%0.55%
-1.4%
Q4 2016$2,333,000329,9420.56%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,579,490$20,146,00022.25%
Novo Holdings A/S 2,901,927$22,664,0002.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 322,436$2,518,0000.96%
Vivo Capital, LLC 300,325$2,346,0000.69%
VHCP Management II, LLC 221,651$1,635,0000.67%
RA Capital Management 591,070$4,616,0000.57%
INTERWEST VENTURE MANAGEMENT CO 329,942$2,577,0000.55%
Eventide Asset Management 98,100$766,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 21,665$169,0000.03%
A.R.T. Advisors, LLC 11,116$86,0000.00%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders